D-0586-2016 Class II Terminated

Recalled by Perrigo Company PLC — Allegan, MI

FDA drug recall D-0586-2016 was initiated by Perrigo Company PLC on Jan 8, 2016 and is designated Class II. Reason for recall: Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups. The recall status is terminated (terminated May 18, 2016).

Recall details

Product Type
Drugs
Report Date
Feb 3, 2016
Initiation Date
Jan 8, 2016
Termination Date
May 18, 2016
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Guaifenesin Grape liquid 100 mg/5 mL, packaged in 4oz. bottles, co-packaged with a dosing cup in a carton and sold under the following: a) H.E.B. Mucus Relief, Children's Guaifenesin, Expectorant, Age 4+, Grape Flavor, Gluten Free, Alcohol Free, 4 FL OZ (118 mL) Bottle, Made for: H.E.B. San Antonio, TX 78204, NDC 37808-288-26; b) CVS, Children's Mucus Relief Chest Congestion, Guaifenesin, Expectorant, Alcohol free, Gluten free, 4 FL OZ (118 mL) Bottle, For Ages 4 to 12 Years, Grape Flavor Liquid, Dosage Cup Included, Distributed by CVS Pharmacy Inc, One CVS Drive, Woonsocket, RI, 02895, NDC 59779-288-26.

Reason for recall

Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups.

Distribution pattern

Nationwide

Code information

Lot #s: 5MK0340, 5LK0592, Exp 08/17

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0586-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0586-2016. Report a data issue: hello@regdatalab.com.